Autologous hematopoietic stem cell transplant (AHSCT) helped resolve watermelon stomach in five people with systemic sclerosis (SSc), researchers in…
Margarida Maia, PhD
Margarida is a biochemist (University of Porto, Portugal) with a PhD in biomedical sciences (VIB and KULeuven, Belgium). Her main interest is science communication. She is also passionate about design and the dialogue between art and science.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Margarida Maia, PhD
In people with systemic sclerosis (SSc), organic solvent exposure — common among workers in industry — is more likely…
Having a higher level of education or being married may mean fewer symptoms of depression for people with systemic…
About half of the people with suspected very early systemic sclerosis (SSc) may go on to develop definite disease,…
aTyr Pharma plans to test efzofitimod, its lead candidate for treating interstitial lung disease (ILD) associated with…
Talaris Therapeutics plans to continue to recruit people with rapidly progressing diffuse cutaneous systemic sclerosis (dcSSc) at risk…
Monitoring the progression of subclinical heart disease with MRI scans suggested that abnormalities remain largely stable over time in people…
The protein ADAR1 occurs in great amounts in macrophages, a type of immune cell that appears in the early stages…
Various immune-related genes are not equally as active in people with systemic sclerosis (SSc) as they are in healthy…
People with systemic scleroderma (SSc) who test positive for cyclic citrullinated peptide (CCP) antibodies are more likely than those who…